Predictive factors for recurrence of papillary thyroid carcinoma: analysis of 4,085 patients
Author:
Publisher
Pacini Editore
Subject
Otorhinolaryngology
Reference25 articles.
1. Wiltshire JJ, Drake TM, Uttley L, et al. Systematic review of trends in the incidence rates of thyroid cancer. Thyroid 2016;26:1541-1552. https://doi.org/10.1089/thy.2016.0100
2. Hundahl SA, Fleming ID, Fremgen AM, et al. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995. Cancer 1998;83:2638-2648. https://doi.org/10.1002/(sici)1097-0142(19981215)83:12<2618::aid-cncr29>3.0.co;2-h
3. Grogan RH, Kaplan SP, Cao H, et al. A study of recurrence and death from papillary thyroid cancer with 27 years of median follow-up. Surgery 2013;154:1436-1446; discussion 1446-1447. https://doi.org/10.1016/j.surg.2013.07.008
4. Nabhan F, Ringel MD. Thyroid nodules and cancer management guidelines: comparisons and controversies. Endocr Relat Cancer 2017;24:R13-R26. https://doi.org/10.1530/ERC-16-0432
5. Cooper DS, Doherty GM, Haugen BR, et al. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009;19:1167-1214. https://doi.org/10.1089/thy.2009.0110
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Screening of serum biomarkers using antibody microarray in diagnosis of papillary thyroid carcinoma;2024-09-08
2. Predictors of response to Radioactive Iodine Therapy in Intermediate and high risk patients with papillary thyroid carcinoma;BMC Endocrine Disorders;2024-07-15
3. Risk factors for cervical lymph node metastasis of papillary thyroid cancer in elderly patients aged 65 and older;Frontiers in Endocrinology;2024-06-24
4. F10 Gene Expression and Ethnic Disparities Present in Papillary Thyroid Carcinoma;Journal of Personalized Medicine;2024-05-15
5. Determining an Approach to Discharge from Oncologic Follow-up in Low-Risk, Well-Differentiated Thyroid Cancer with Excellent Response To Initial Therapy;Clinical Thyroidology®;2024-05-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3